MMRGlobal Reports Q2 & Year-to-Date Results

LOS ANGELES, CA--(Marketwired - Aug 15, 2014) - MMRGlobal, Inc. (OTCQB: MMRF) ("MMR" or the "Company") reported in its 10-Q filed August 14, 2014 that for the six months ended June 30, 2014, revenues were 26% greater over 2013 despite the fact that second quarter revenues were lower for the same period last year. The Company was also focused on its ongoing patent litigation matters during the second quarter. In particular, MyMedicalRecords, Inc., a wholly owned subsidiary of MMRGlobal, has been preparing for an upcoming Markman hearing pertaining to two of its patents, which is scheduled for August 19, 2014 (MyMedicalRecords, Inc., United States District Court for the Central District of California, at http://www.pacer.gov/).

Notwithstanding the overall increase for the six-month period as compared to 2013, the Company expressed disappointment over the fact that certain events did not materialize in the second quarter, including an earlier release date of its MyMedicalRecords Personal Health Record Kit, which began appearing for sale in the third quarter, specifically on August 1, 2014 (goo.gl/RKTLwz).

In addition to the Company's continued focus on products, services and sales during the second quarter, the Company expanded its marketing efforts through the launch of an enriched content site, which can be seen at http://goo.gl/vNIWp1 and will be available to retailers through Answers' Webcollage network (http://www.webcollage.com/feature-tour/impressive-product-stories/). Webcollage syndicates dynamic product content to more than 500 retailers including Target, Staples, Costco, Best Buy and Lowe's.

During the second quarter, the Company's attention also continued to be focused on the protection and licensing of its intellectual property, including monetizing its biotech assets, and in the licensing and selling of its MyMedicalRecords Personal Health Record products and services, as evidenced by the signing of additional licensing agreements with Salutopia and Claydata during an MMR trip to Australia.

According to MMRGlobal Chairman and CEO Robert H. Lorsch, "While our second quarter revenue was disappointing, we are pleased with our six-month performance and the other accomplishments we made in the second quarter towards creating a stronger foundation for the Company moving forward. We expect that our efforts during the second quarter, particularly with respect to the focus on the launching of our products to retailers and continued licensing of our intellectual property, will result in financial growth during future quarters." The Company plans on reporting revenues from retail sales of its Personal Health Record Kit starting in the third quarter public filings.